BioCentury
ARTICLE | Financial News

Novira raises $23M in series A

August 25, 2012 12:04 AM UTC

Novira Therapeutics Inc. (Radnor, Pa.) raised $23 million in a series A round co-led by new investors 5AM Ventures and Canaan Partners. New investor WuXi PharmaTech Inc. (NYSE:WX) also participated, along with existing investors BioAdvance; Mid-Atlantic Angel Group; Robin Hood Ventures; and Delaware Crossing Investment Group. Novira is developing viral capsid assembly inhibitors to treat HBV and HIV infections. The company hopes to begin clinical testing of a lead HBV candidate in 2014. Novira was founded in 2009 (see BioCentury, Aug. 29, 2011). ...